IM

ImmunityBio

IBRX
NASDAQHealth Care

Recent Patents

ibrx
1 year ago

Filed a patent for "lair-2 compositions and methods" on Tue, July 25, 2023

New US Patent
ibrx
over 1 year ago

Filed a patent for "ex vivo generation of immune effector cells from apheresis material intermediates" on Wed, July 5, 2023

New US Patent
ibrx
over 1 year ago

Filed a patent for "ex vivo generation of immune effector cells from apheresis material intermediates" on Tue, July 25, 2023

New US Patent
ibrx
over 1 year ago

Filed a patent for "ex vivo generation of immune effector cells from apheresis material intermediates" on Fri, December 1, 2023

New US Patent
ibrx
over 1 year ago

Filed a patent for "albumin bound macromolecule activating tri-agonist receptors glp-1/gip/glucagon" on Mon, March 4, 2024

New US Patent
ibrx
over 1 year ago

Filed a patent for "albumin bound macromolecule activating tri-agonist receptors glp-1/gip/glucagon" on Tue, March 12, 2024

New US Patent
ibrx
over 1 year ago

Filed a patent for "generation of chimeric antigen receptor mrna molecules for expression in primary nk cells" on Wed, January 17, 2024

New US Patent
ibrx
over 1 year ago

Filed a patent for "training natural language processing models using modified cross entropy loss functions" on Thu, November 7, 2024

New US Patent
ibrx
over 1 year ago

Filed a patent for "adenoviral vector transduced apheresis product" on Thu, May 4, 2023

New US Patent
ibrx
over 1 year ago

Filed a patent for "il-12/il-18 superkines" on Fri, March 31, 2023

New US Patent
ibrx
over 1 year ago

Filed a patent for "il-12/il-18 superkines" on Thu, October 3, 2024

New US Patent
ibrx
over 1 year ago

Filed a patent for "method for stimulating tumor-infiltrating lymphocytes with an il-15:il-15r complex" on Thu, September 12, 2024

New US Patent
ibrx
over 1 year ago

Filed a patent for "bacillus calmette-guerin (bcg) and antigen presenting cells for treatment of bladder cancer" on Thu, September 5, 2024

New US Patent
ibrx
over 1 year ago

Filed a patent for "il-15-based fusions to il-12 and il-18" on Thu, August 1, 2024

New US Patent
ibrx
over 1 year ago

Filed a patent for "electroporation with active compensation" on Thu, July 11, 2024

New US Patent
ibrx
over 1 year ago

Filed a patent for "nant covid vaccine cross reactivity" on Thu, July 11, 2024

New US Patent
ibrx
over 1 year ago

Filed a patent for "compositions comprising il-15n72d-based molecules and bacillus calmette-guerin (bcg)" on Thu, August 1, 2024

New US Patent
ibrx
over 1 year ago

Filed a patent for "il-15-based molecules and methods of use thereof" on Thu, August 8, 2024

New US Patent
ibrx
almost 2 years ago

Filed a patent for "modified t cell receptors for the prevention and treatment of viral infections and cancer" on Thu, January 18, 2024

New US Patent
ibrx
almost 2 years ago

Filed a patent for "elimination of bcma-positive malignancies by car expressing nk cells" on Thu, June 8, 2023

New US Patent
ibrx
almost 2 years ago

Filed a patent for "systems and methods of analyzing microbiomes using artificial intelligence" on Thu, August 4, 2022

New US Patent
ibrx
almost 2 years ago

Filed a patent for "content authentication and validation via multi-factor digital tokens, systems, and methods" on Thu, December 22, 2022

New US Patent
ibrx
almost 2 years ago

Filed a patent for "nant covid vaccine cross reactivity" on Thu, June 22, 2023

New US Patent
ibrx
almost 2 years ago

Filed a patent for "neoepitope vaccine delivery vehicle and methods of making the same" on Thu, June 8, 2023

New US Patent
ibrx
almost 2 years ago

Filed a patent for "method of treating cancer with composition comprising il-15-based molecules and bcg" on Thu, August 3, 2023

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...